SCHEDULE: Sargent Investment Group Discloses 5.79% Stake in PAVmed

Sargent Investment Group, LLC has reported a beneficial ownership of 5.79% in PAVmed Inc.'s common stock, totaling 1,006,300 shares.

Summary

• Sargent Investment Group, LLC filed a Schedule 13G, indicating beneficial ownership in PAVmed Inc.
• The filing reports ownership of 1,006,300 shares of PAVmed Inc. common stock.
• This stake represents 5.79% of the total outstanding common stock of PAVmed Inc.
• Sargent Investment Group, LLC is classified as an investment adviser.
• The shares are held with shared voting power and sole dispositive power by Sargent Investment Group, LLC.

Sentiment

Score: 6

Explanation: The filing is a factual report of beneficial ownership. While not directly financial performance, a new significant institutional investor can be seen as a positive signal, hence a slightly positive score.

Positives

• A significant institutional investor, Sargent Investment Group, LLC, has taken a notable stake in PAVmed Inc., potentially signaling confidence in the company's long-term prospects.

Negatives

• NA

Risks

• The filing itself does not detail specific operational or financial risks of PAVmed Inc., as it is a beneficial ownership report.

Future Outlook

This filing is a beneficial ownership report and does not contain forward-looking statements or guidance regarding PAVmed Inc.'s future performance or operations.

Industry Context

This filing indicates a new or increased institutional investment in PAVmed Inc., a medical technology company. Such disclosures are common in the financial industry as investment firms adjust their portfolios based on market opportunities and company performance. The entry of a new significant shareholder can sometimes be viewed positively by the market, suggesting external validation of the company's value proposition.

Stakeholder Impact

• Shareholders: The disclosure of a new significant institutional investor may positively influence investor sentiment and potentially the stock price, indicating increased institutional interest in PAVmed Inc.

Key Dates

Keywords

PAVmed Inc., Sargent Investment Group, Beneficial Ownership, Schedule 13G, Common Stock, Investment Adviser, Institutional Ownership